November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Compound Ebselen Shows Potential in Dismantling Resistant Bacterial Biofilms

🥗 Nutrition 1 min read 👁 2

A recent study published in Nature Health Sciences reveals that the organoselenium compound Ebselen may effectively disrupt drug-resistant bacterial biofilms by targeting amino acid metabolism.

🥗Nutrition

Key points

  • Ebselen disrupts methicillin-resistant Staphylococcus aureus biofilms.
  • The compound targets the ArgR protein to alter arginine metabolism.
  • Preclinical models showed reduced bacterial burden in implant and urinary tract infections.

Researchers investigating treatments for drug-resistant microbial strains have identified that the small molecule Ebselen may successfully impair mature biofilms formed by methicillin-resistant Staphylococcus aureus and other Gram-positive pathogens. Published in Nature Health Sciences, the study explored how these stubborn bacterial communities pose serious clinical obstacles due to their high tolerance for standard antibiotics and adaptive metabolic traits.

Through laboratory testing and clinically relevant animal models involving implant-associated osteomyelitis and catheter-related urinary tract infections, the investigation demonstrated that Ebselen substantially lowered bacterial loads and disease progression. Advanced structural and multi-omics analyses pinpointed a specific protein regulator, ArgR, as the primary molecular target of the compound, which disrupts bacterial arginine homeostasis and destabilizes biofilm integrity.

What to know: While these early findings suggest a novel approach to tackling multidrug-resistant infections, the research remains in preclinical stages using animal and laboratory models. Readers should consult qualified healthcare professionals for guidance concerning any medical conditions or treatments.

Targeting metabolic pathways such as arginine homeostasis offers a promising strategy to weaken resilient bacterial populations.

Source Nature Health Sciences — nature.com/articles/s41522-026-01176-4 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.